a neolactoside VIII3- α- GalNAc,VIII2- α- Fuc,IV6- β- [GalNAc- α- (1→3)- (Fuc- α- (1→2))- Gal- β- (1→4)- GlcNAc]- nLc8Cer(d18:0)
|
UniProt
|
α- D- GalNAc- (1→3)- [α- L- Fuc- (1→2)]- β- D- Gal- (1→4)- β- D- GlcNAc- (1→3)- β- D- Gal- (1→4)- β- D- GlcNAc- (1→3)- [α- D- GalNAc- (1→3)- (α- L- Fuc- (1→2))- β- D- Gal- (1→4)- β- D- GlcNAc- (1→6)]- β- D- Gal- (1→4)- β- D- GlcNAc- (1→3)- β- D- Gal- (1→4)- β- D- Glc- (1↔1ʼ)- Cer(d18:0)
|
SUBMITTER
|
blood group type II chain Ad (d18:0)
|
SUBMITTER
|
N- acetyl- α- D- galactosaminyl- (1→3)- [α- L- fucosyl- (1→2)]- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- [N- acetyl- α- D- galactosaminyl- (1→3)- (α- L- fucosyl- (1→2))- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→6)]- β- D- galactosyl- (1→4)- N- acetyl- β- D- glucosaminyl- (1→3)- β- D- galactosyl- (1→4)- β- D- glucosyl- (1↔1ʼ)- N- acylsphinganine
|
SUBMITTER
|